Molecular classification and overcoming therapy resistance for acute myeloid leukemia with adverse genetic factors

HIGHLIGHTS

• who: Daisuke Ikeda and colleagues from the Department of Hematology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan have published the paper: Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors, in the Journal: (JOURNAL)
• what: The authors focus on the biological background and real-world etiology of these adverse genetic factors and then describe a strategy to overcome the clinical disadvantages in terms of targeting pivotal molecular mechanisms. The ad hoc analysis of the AML201 study focused 8 of 22 on 197 patients in which comprehensive genetic data were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.